Genetic Literacy Project says unapproved peptide sales outpace federal regulators
The piece describes an online market for unapproved peptides expanding faster than FDA enforcement can respond.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 19 00:02 ETSource: Genetic Literacy Project
The wire
- 01The report characterizes a fast-growing online trade in unapproved peptides that federal regulators have not kept pace with.
- 02Clinicians and compounders face patients sourcing research-labeled peptides outside any prescription or pharmacy channel.
- 03Only the headline is available; specific enforcement actions, products and agency statements should be verified in the full article.
From the source
Read at geneticliteracyproject.orgOnline gold rush of unapproved peptides is outrunning federal regulators
